A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Upadacitinib in Pediatric Participants With Severe Atopic Dermatitis
Clinical trial NCT03646604 · COMPLETED
Trial details
- NCT number
- NCT03646604
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-31
- Primary completion
- 2024-08-29
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.